Duke scientist’s cancer research is questioned
Washington Post, July 25, 2010
Concerns are being raised about the validity of research done by a Duke University cancer scientist who recently was placed on leave while the school investigates whether he falsely claimed to be a Rhodes scholar. The editor of a British journal, Lancet Oncology, issued an "expression of concern" Friday, citing a December 2007 study it published from Dr. Anil Potti and others. The study described gene patterns that might help predict a breast cancer patient's response to chemotherapy. The journal said two of Potti's co-authors had contacted them this week on behalf of 15 European scientists involved in the study with "grave concerns about the validity of their report."
Most Viewed
Most Emailed
- $6.4B Henry Ford, Beaumont Merger Failed on Cultural Hurdles
- Don't Let Nurses Sink Your Bottom Line
- Hospitals Profit On Bloodstream Infections
- Fortunately, Angelina Jolie Isn't On Medicare
- Less Blood Testing for Some Surgeries Safe, Cost Effective
- Lower ED Margins Demand a Better Strategy
- How Chargemaster Data May Affect Hospital Revenue
- Primary Care Docs Average More Hospital Revenue Than Specialists
- House Lawmakers Grill CMS Over Health Exchange Navigators
- ED Physicians Key to Half of Hospital Admissions
